Withings Study to Analyze the Accuracy of Pulse Wave Velocity Measurement With Bathroom Scales (WIVOP-Scales)

Withings Study to Analyze the Accuracy of Pulse Wave Velocity Measurement With Bathroom Scales

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05823025

Acronym

WIVOP-Scales

Enrollment

176

Registered

2023-04-21

Start date

2023-06-16

Completion date

2026-12-02

Last updated

2026-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vascular Stiffness

Brief summary

The aim of this study is to evaluate the diagnostic performance of Withings bathroom scales WBS08 and WBS12 to measure PWV (Pulse Wave Velocity).

Detailed description

Patients likely to have a high PWV (having hypertension, sleep apnea or chronic obstructive pulmonary disease) are included in hospitals. Each patient will have his PWV measured with Withings WBS08 and WBS12 and its reference the SphygmoCor CvMS.

Interventions

OTHERPWV measurement

Patient will have its PWV measured with the reference (the SphygmoCor) and by stepping on Withings bathroom scales WBS08 and WBS12.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* The subject is an adult, man or woman (18 years old or more), * Subjects affiliated or eligible to a social security system, * Subjects having expressed their consent to take part in the study. * Two subsets of patients will be included in the study : * Hypertensive patient * Patient having sleep apnea or COPD (Chronic obstructive pulmonary disease)

Exclusion criteria

* Minors under 18 years old, * Subject is pregnant, * Subjects having a pacemaker or an ICD (Implantable cardioverter defibrillator), * Subjects having refused to give their consent, * Vulnerable subjects according to the French regulation in force: * Individuals deprived of liberty by a court, medical or administrative order, * Individuals legally protected or unable to express their consent to take part in the study, * Individuals unaffiliated to or not beneficiary of a social security system, * Individuals who fit in multiple categories above, * Individuals linguistically or mentally unable to express their consent, * Individuals having a lower limb amputation bigger than toes, * Individuals not able to stand still for a few minutes.

Design outcomes

Primary

Measure	Time frame	Description
PWV measurement bias	1 year	Difference between the PWV measured and the PWV reference (m.s-1)
PWV measurement deviation	1 year	The standard deviation of the difference between the PWV measured and the PWV reference (m.s-1)

Secondary

Measure	Time frame	Description
Safety use	1 year	The percentage of participant having adverse effects over the total number of participant included.

Countries

France

Contacts

PRINCIPAL_INVESTIGATORPierre Boutouyrie, Pr

Georges Pompidou european hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026